Monique C. Haak
Leiden University Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Monique C. Haak.
Ultrasound in Obstetrics & Gynecology | 2008
L. B. Uittenbogaard; Monique C. Haak; Marieke D. Spreeuwenberg; J. M. G. van Vugt
To investigate the feasibility of incorporating spatiotemporal image correlation (STIC) into a tertiary fetal echocardiography program.
PLOS Medicine | 2012
David van der Ham; Sylvia M. C. Vijgen; Jan G. Nijhuis; Johannes J. van Beek; Brent C. Opmeer; Antonius L.M. Mulder; Rob Moonen; Mariet Groenewout; Marielle van Pampus; Gerald Mantel; Kitty W. M. Bloemenkamp; Wim van Wijngaarden; Marko Sikkema; Monique C. Haak; Paula Pernet; Martina Porath; Jan Molkenboer; Simone Kuppens; Anneke Kwee; Michael Kars; Mallory Woiski; Martin Weinans; Hajo I. J. Wildschut; Bettina M.C. Akerboom; Ben Willem J. Mol; Christine Willekes
In a randomized controlled trial David van der Ham and colleagues investigate induction of labor versus expectant management for women with preterm prelabor rupture of membranes.
Ultrasound in Obstetrics & Gynecology | 2015
Maribel Grande; F. A. R. Jansen; Yair J. Blumenfeld; Allan Fisher; Anthony Odibo; Monique C. Haak; Antoni Borrell
To estimate the incremental yield of detecting copy number variants (CNVs) by genomic microarray over karyotyping in fetuses with increased nuchal translucency (NT) diagnosed by first‐trimester ultrasound.
Ultrasound in Obstetrics & Gynecology | 2009
L. B. Uittenbogaard; Monique C. Haak; Marieke D. Spreeuwenberg; J. M. G. van Vugt
The goal of this study was to use spatiotemporal image correlation (STIC) to provide reference values for left and right ventricle volumes, and indices of fetal cardiac function.
Ultrasound in Obstetrics & Gynecology | 2015
F. A. R. Jansen; Yair J. Blumenfeld; A. Fisher; J. M. Cobben; Anthony Odibo; Antoni Borrell; Monique C. Haak
Array comparative genomic hybridization (aCGH) is a molecular cytogenetic technique that is able to detect the presence of copy number variants (CNVs) within the genome. The detection rate of imbalances by aCGH compared to standard karyotyping and 22q11 microdeletion analysis by fluorescence in‐situ hybridization (FISH), in the setting of prenatally‐diagnosed cardiac malformations, has been reported in several studies. The objective of our study was to perform a systematic literature review and meta‐analysis to document the additional diagnostic gain of using aCGH in cases of congenital heart disease (CHD) diagnosed by prenatal ultrasound examination, with the aim of assisting clinicians to determine whether aCGH analysis is warranted when an ultrasonographic diagnosis of CHD is made, and to guide counseling in this setting.
Developmental Dynamics | 2004
Adriana C. Gittenberger-de Groot; Nynke M.S. van den Akker; Margot M. Bartelings; Sandra Webb; John M.G. van Vugt; Monique C. Haak
Ultrasound measurement of increased nuchal translucency is a method of risk assessment for heart malformations and trisomy 21 in human pregnancy. The developmental background of this nuchal edema is still not sufficiently understood. We have studied the process in trisomy 16 mice that show nuchal edema and heart malformations. We used trisomy 16 and wild‐type (WT) embryos from embryonic day (E) 12.5 to E18.5. In WT embryos at E13, bilateral jugular lymphatic sacs are visible that share a lymphatic–venous membrane with the jugular vein. We could not in any case discern a valve between these vessels. At E14 in the TS16 embryos, the lymphatic sacs become enlarged showing abnormally thickened endothelium, specifically at the site of the membrane. In these embryos, severe edema develops in the nuchal region. There is a very close colocalisation of the nerves with the vascular structures. The start of reorganization of the jugular lymphatic sac to a lymph node is observed in both wild‐type and TS16 but is diminished in the latter. In conclusion, abnormal size and structure of the jugular lymphatic sacs coincides with the development of nuchal edema. A disturbance of lymphangiogenesis might be the basis for increased nuchal translucency that is often observed in diseased human fetuses. Developmental Dynamics 230:378–384, 2004.
Ultrasound in Obstetrics & Gynecology | 2005
Mireille N. Bekker; Monique C. Haak; M. Rekoert-Hollander; Jos W. R. Twisk; J. M. G. van Vugt
To investigate the presence and volume of jugular lymphatic sacs (JLS) in first‐trimester fetuses with normal nuchal translucency thickness (NT) and in those with increased NT.
Ultrasound in Obstetrics & Gynecology | 2012
B. Adriaanse; C. H. N. Tromp; John M. Simpson; T. Van Mieghem; Willem Kist; D. J. Kuik; Dick Oepkes; J.M.G. van Vugt; Monique C. Haak
To evaluate the clinical accuracy of four‐dimensional (4D) echocardiography in the detailed prenatal diagnosis of congenital heart disease (CHD) in a telemedicine setting.
Journal of The Society for Gynecologic Investigation | 2006
Mireille N. Bekker; Nynke M. S. van den Akker; Margot M. Bartelings; Jenny B. Arkesteijn; Sigrid G. L. Fischer; Japke A.E. Polman; Monique C. Haak; Sandra Webb; Robert E. Poelmann; John M.G. van Vugt; Adriana C. Gittenberger-de Groot
Objective: Nuchal edema (NE) is a clinical indicator for aneuploidy, cardiovascular anomalies, and several genetic syndromes. Its etiology, however, is unknown. In the nuchal area, the endothelium of the jugular lymphatic sacs (JLS) develops by budding from the blood vascular endothelium of the cardinal veins. Abnormal distension of the jugular sacs is associated with NE. We hypothesize that a disturbed lymphatic endothelial differentiation and sac formation causes NE. We investigated endothelial differentiation of the jugular lymphatic system in human and mouse species with NE. Methods: Aneuploid human fetuses (trisomy 21; trisomy 18) were compared with euploid controls (gestational age 12 to 18 weeks). Trisomy 16 mouse embryos were compared with wild type controls (embryonic day 10 to 18). Trisomy 16 mice are considered an animal model for human trisomy 21. Endothelial differentiation was investigated by immunohistochemistry using lymphatic markers (prox-1, podoplanin, lymphatic vessel endothelial hyaluronan receptor [LYVE]-1) and en blood vessel markers (neuropilin [NP]-1 and ligand vascular endothelial growth factor [VEGF]-A). Smooth muscle actin (SMA) was included as a smooth muscle cell marker. Results: We report a disturbed venous-lymphatic phenotype in aneuploid human fetuses and mouse embryos with enlarged jugular sacs and NE. Our results show absent or diminished expression of the lymphatic markers Prox-1 and podoplanin in the enlarged jugular sac, while LYVE-1 expression was normal. Additionally, the enlarged JLS showed blood vessel characteristics, including increased NP-1 and VEGF-A expression. The lumen contained blood cells and smooth muscle cells lined the wall. Conclusion: A loss of lymphatic identity seems to be the underlying cause for clinical NE. Also, abnormal endothelial differentiation provides a link to the cardiovascular anomalies associated with NE.
Ultrasound in Obstetrics & Gynecology | 2005
Monique C. Haak; Jos W. R. Twisk; Margot M. Bartelings; A.C. Gittenberger-de Groot; J. M. G. van Vugt
To study intracardiac flow velocities in first‐trimester fetuses with normal nuchal translucency thickness (NT) and those with increased NT.